The Metabolic Medicine Department at Salford Royal is one of the leading departments in Europe for treating and managing Adult Inherited Metabolic Disorders.

It is one of only four dedicated Adult Inherited Metabolic Disorder centres within England, providing a service for the North of England but also accepting patients from other geographical areas including Northern Ireland, Scotland and Wales.

The department undertakes clinical trials into rare genetic disorders and is at the forefront of drug development studies.

The multi-disciplinary team, led by Professor Mark Roberts, conduct a number of Phase 1 trials. In 2023 they delivered their first gene therapy study for the treatment of Gaucher disease and recruited the first UK participant, one of several UK, European and global firsts in the last decade.

The dedicated research team work closely with colleagues across NCA to ensure that rare disease patients have a voice and a potential future through research that wasn’t possible previously.